Pleased to share that BrightEdge, @AmericanCancer’s donor-funded philanthropic impact fund, has invested in @freenome, a biotech company focused on cancer detection via blood draw. We think this tech is promising & could lead to improved patient outcomes. http://bwnews.pr/2Zf4giM pic.twitter.com/cmg03rZnf9
18:09 - 24. srp 2019.
0 replies
23 proslijeđena tweeta
46 korisnika označava da im se sviđa
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.